Entera Stock Buy Hold or Sell Recommendation

ENTX
 Stock
  

USD 1.88  0.10  5.62%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Entera Bio is 'Hold'. Macroaxis provides Entera Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ENTX positions. The advice algorithm takes into account all of Entera Bio's available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Entera Bio's buy-and-hold perspective. Continue to Entera Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Entera and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Entera Bio.

Execute Entera Bio Buy or Sell Advice

The Entera recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Entera Bio. Macroaxis does not own or have any residual interests in Entera Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Entera Bio's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Entera BioBuy Entera Bio
Hold

Volatility

RiskyDetails

Hype Condition

StaleDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Close to AverageDetails

Economic Sensitivity

Almost mirrors the marketDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Entera Bio has a Risk Adjusted Performance of (0.03961), Jensen Alpha of (0.26), Total Risk Alpha of (0.32) and Treynor Ratio of (0.23)
We provide trade advice to complement the prevailing expert consensus on Entera Bio. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Entera Bio is not overpriced, please confirm all Entera Bio fundamentals, including its net income, as well as the relationship between the book value per share and market capitalization . Please also check Entera Bio price to earning to verify your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Entera Bio Trading Alerts and Improvement Suggestions

Entera Bio generated a negative expected return over the last 90 days
Entera Bio has high historical volatility and very poor performance
Entera Bio may become a speculative penny stock
Entera Bio was previously known as Entera Bio and was traded on NASDAQ Exchange under the symbol ENTXW.
The company reported the previous year's revenue of 482 K. Net Loss for the year was (13.68 M) with profit before overhead, payroll, taxes, and interest of 198 K.
Entera Bio currently holds about 20.11 M in cash with (11.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7.
Entera Bio has a poor financial position based on the latest SEC disclosures
Roughly 23.0% of the company shares are held by company insiders
Latest headline from www.benzinga.com: 5.1 Million Bet On Tabula Rasa HealthCare 3 Penny Stocks Insiders Are Buying - Benzinga - Benzinga

Entera Bio current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Entera analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Entera analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price6.50
Target Median Price6.00
Target High Price9.00
Recommendation Mean2.00
Number Of Analyst Opinions4
Target Low Price5.00
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Entera Bio Returns Distribution Density

The distribution of Entera Bio's historical returns is an attempt to chart the future uncertainty of Entera Bio's future price movements. The chart of the probability distribution of Entera Bio stock daily returns describes the distribution of returns around its average expected value. We use Entera Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Entera Bio returns is essential to provide solid investment advice for Entera Bio stock.
Mean Return-0.23Value At Risk-9.17
Potential Upside8.38Standard Deviation6.10
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Entera Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Entera Bio Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(51 K)(68 K)(40 K)(53 K)(17 K)(18.34 K)
Depreciation Amortization and Accretion43 K54 K238 K63 K53 K74.79 K
Net Cash Flow or Change in Cash and Cash Equivalents7.58 M(4.24 M)7.68 M(6.56 M)16.3 M17.59 M
Net Cash Flow from Financing11.11 M9.62 M12.65 M4.05 M25.38 M20.12 M
Net Cash Flow from Investing1 M(4.07 M)3.95 M(53 K)(17 K)(18.34 K)
Net Cash Flow from Operations(4.53 M)(9.8 M)(8.92 M)(10.56 M)(9.06 M)(9.78 M)
Share Based Compensation4.88 M1.23 M1.48 M901 K1.86 M1.81 M

Entera Bio Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Entera Bio or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Entera Bio stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Entera stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.26
β
Beta against DOW1.05
σ
Overall volatility
5.92
Ir
Information ratio -0.04

Entera Bio Volatility Alert

Entera Bio is displaying above-average volatility over the selected time horizon. Investors should scrutinize Entera Bio independently to ensure intended market timing strategies are aligned with expectations about Entera Bio volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Entera Bio's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Entera Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Entera Bio Implied Volatility

Entera Bio's implied volatility" href="/stock-options/ENTX/Entera-Bio">Entera Bio's implied volatility exposes the market's sentiment of Entera Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Entera Bio's implied volatility" href="/stock-options/ENTX/Entera-Bio">Entera Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Entera Bio stock will not fluctuate a lot when Entera Bio's options" href="/stock-options/ENTX/Entera-Bio">Entera Bio's options are near their expiration.

Entera Bio Fundamentals Vs Peers

Comparing Entera Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Entera Bio's direct or indirect competition across all of the common fundamentals between Entera Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Entera Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Entera Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Entera Bio by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Entera Bio to competition
FundamentalsEntera BioPeer Average
Return On Equity(99.97) %(0.31) %
Return On Asset(41.97) %(0.14) %
Current Valuation36.01 M16.62 B
Shares Outstanding28.78 M571.82 M
Shares Owned by Insiders23.37 %10.09 %
Shares Owned by Institutions17.18 %39.21 %
Number of Shares Shorted78.24 K4.71 M
Price to Earning2.10 X28.72 X
Price to Book2.02 X9.51 X
Price to Sales108.69 X11.42 X
Revenue482 K9.43 B
Gross Profit198 K27.38 B
EBITDA(13.65 M)3.9 B
Net Income(13.68 M)570.98 M
Cash and Equivalents20.11 M2.7 B
Cash per Share0.70 X5.01 X
Total Debt240 K5.32 B
Debt to Equity0.012 %48.70 %
Current Ratio9.27 X2.16 X
Book Value Per Share0.90 X1.93 K
Cash Flow from Operations(11.53 M)971.22 M
Short Ratio2.52 X4.00 X
Earnings Per Share(0.83) X3.12 X
Number of Employees2118.84 K
Beta1.81-0.15
Market Capitalization52.39 M19.03 B
Total Asset9.47 M29.47 B
Retained Earnings(67.88 M)9.33 B
Working Capital817.29 K1.48 B
Current Asset8.46 M9.34 B
Current Liabilities7.64 M7.9 B
   Entera Bio exotic insider transaction detected [view details]

Entera Bio Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Entera . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution659.57
Daily Balance Of Power1.25
Rate Of Daily Change1.06
Day Median Price1.84
Day Typical Price1.85
Market Facilitation Index0.0
Price Action Indicator0.09

About Entera Bio Buy or Sell Advice

When is the right time to buy or sell Entera Bio? Buying financial instruments such as Entera Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Entera Bio investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Current Assets15.64 M9.11 M25.33 M21.09 M
Total Assets16.7 M9.72 M25.99 M21.91 M

Use Investing Ideas to Build Portfolios

In addition to having Entera Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Tech Growth Thematic Idea Now

Tech Growth
Tech Growth Theme
Instruments that are typically traded at high earnings multiples compared to their competitors and other sectors and have been known to drive market cycles frequently. The Tech Growth theme has 65 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Growth Theme or any other thematic opportunities.
View All  Next Launch
Continue to Entera Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Entera Bio information on this page should be used as a complementary analysis to other Entera Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Entera Stock analysis

When running Entera Bio price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Is Entera Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entera Bio. If investors know Entera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entera Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
52.4 M
Quarterly Revenue Growth YOY
-0.57
Return On Assets
-0.42
Return On Equity
-1.0
The market value of Entera Bio is measured differently than its book value, which is the value of Entera that is recorded on the company's balance sheet. Investors also form their own opinion of Entera Bio's value that differs from its market value or its book value, called intrinsic value, which is Entera Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entera Bio's market value can be influenced by many factors that don't directly affect Entera Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Entera Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Entera Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entera Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.